Hereditary Angioedema Patients Reported Treatment Burdens
A new study reveals how treatment pain and delivery methods influence care choices for those managing HAE attacks.
Updated on Oct. 5, 2026 in Allergies
Live Poll
Should treatment convenience be as important as clinical effectiveness when choosing a chronic disease medication?
Researchers have identified significant gaps between clinical guidelines and the real-world experiences of patients living with hereditary angioedema (HAE). The findings highlight how the burden of injectable treatments leads many patients to skip care for HAE attacks.
Why it matters
Understanding patient preferences for oral versus injectable treatments helps explain why many do not treat every HAE attack. This data provides insights into how treatment convenience impacts clinical outcomes and adherence.
A retrospective survey of 1,131 patients and 225 physicians across the United States, Europe, and Japan examined real-world patterns of HAE management. The data, published in Advances in Therapy, indicates that many patients avoid injectable treatments due to pain and administration burden.
The players
Pharvaris
A Zug, Switzerland-based pharmaceutical company focused on developing therapies for bradykinin-mediated angioedema.
The details
The analysis compared physician-reported clinical data with direct patient insights to evaluate disease management strategies. Many patients reported favoring daily oral options over injectable prophylaxis because they perceive current injection methods as painful or overly burdensome. This disconnect often results in patients choosing not to treat attacks they deem less severe, highlighting a discrepancy between standard care guidelines and patient behavior.
Timeline
The retrospective survey collected data from January 2023 through January 2024.
The analysis was published in Advances in Therapy on October 5, 2026.
Health Landscape
This analysis leverages the Adelphi Real World HAE Disease Specific Programme to quantify the disconnect between formal clinical guidelines and real-world patient choices. It reflects a broader shift toward integrating patient-reported experience data into the standard of care for chronic diseases.
If you are managing hereditary angioedema and find current treatment protocols burdensome or painful, these findings highlight the importance of discussing your preferences with your physician. Openly communicating your challenges with specific routes of administration can help your care team identify appropriate, patient-centered management options.
The takeaway
Patient treatment satisfaction is significantly tied to the ease of use and administration method of their medication. If you are struggling with a treatment regimen, consult your physician to explore alternative options that better fit your daily life and comfort levels.
Further reading
For more on managing triggers and care protocols, visit our Allergies section.
More information
Review the full publication of study analysis in Advances in Therapy for complete data findings.
Live Poll
Should treatment convenience be as important as clinical effectiveness when choosing a chronic disease medication?
